drugset
drugset / Trial / NCT07275775

Single and Multiple Dose and Food Effect Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-2570 Tablets in Healthy Subjects

NCT07275775 ↗

Phase 1 Completed 100 enrolled InventisBio Co., Ltd
RandomizedParallel-groupQuadruple-blindBasic science

Summary

This is a randomized, double-blind, placebo-controlled single and multiple ascending dose and food effect study on PK. Subjects in the SAD and MAD study take the drug under fasting conditions, while those in the food effect (FE) study are required to take the drug under fasting or fed conditions according to the protocol.

Timeline

Start
2024-08-13
Primary completion
2025-06-23
Completion
2025-06-23

Drugs

EvaluationDrugModalityDoseRoute
Subject D-2570 Unknown 3 mg Oral
Subject D-2570 Unknown 9 mg Oral

Indications

No indication recorded.